These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38371879)

  • 1. miR-182 Promotes Tumor Growth and Increases Chemoresistance of Human Anaplastic Thyroid Cancer by Targeting Tripartite Motif 8 [Retraction].
    Onco Targets Ther; 2024; 17():101-102. PubMed ID: 38371879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8.
    Liu Y; Zhang B; Shi T; Qin H
    Onco Targets Ther; 2017; 10():1115-1122. PubMed ID: 28280352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction].
    Onco Targets Ther; 2023; 16():1025-1026. PubMed ID: 38090111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction].
    Onco Targets Ther; 2021; 14():3597. PubMed ID: 34113125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction].
    Onco Targets Ther; 2023; 16():801-802. PubMed ID: 37794861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction].
    Onco Targets Ther; 2022; 15():1317-1318. PubMed ID: 36338438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG16 Drives Proliferation and Invasion of Papillary Thyroid Cancer Through Modulation of miR-497 [Retraction].
    Onco Targets Ther; 2021; 14():4747-4748. PubMed ID: 34526782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction].
    Onco Targets Ther; 2023; 16():749-750. PubMed ID: 37727440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00152 Promotes the Growth and Invasion of Oral Squamous Cell Carcinoma by Regulating miR-139-5p [Retraction].
    Onco Targets Ther; 2021; 14():4297. PubMed ID: 34349521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0005576 Promotes Malignant Progression Through miR-874/CDK8 Axis in Colorectal Cancer [Retraction].
    Onco Targets Ther; 2023; 16():327-328. PubMed ID: 37223124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis [Retraction].
    Onco Targets Ther; 2022; 15():133-134. PubMed ID: 35115788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circGSE1 Promotes Cervical Cancer Progression Through miR-138-5p/Vimentin [Retraction].
    Onco Targets Ther; 2022; 15():759-760. PubMed ID: 35855756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA EWSAT1 Promotes Colorectal Cancer Progression Through Sponging miR-326 to Modulate FBXL20 Expression [Retraction].
    Onco Targets Ther; 2023; 16():845-846. PubMed ID: 37881684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction].
    Onco Targets Ther; 2023; 16():1013-1014. PubMed ID: 38047059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA EGOT Promotes the Malignant Phenotypes of Hepatocellular Carcinoma Cells and Increases the Expression of HMGA2 via Down-Regulating miR-33a-5p [Retraction].
    Onco Targets Ther; 2022; 15():1121-1122. PubMed ID: 36221288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APE1 Axis [Retraction].
    Onco Targets Ther; 2022; 15():701-702. PubMed ID: 35769126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-488 Inhibits Cell Growth and Metastasis in Renal Cell Carcinoma by Targeting HMGN5 [Retraction].
    Onco Targets Ther; 2021; 14():3351. PubMed ID: 34045871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction].
    Onco Targets Ther; 2023; 16():261-262. PubMed ID: 37065775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating
    Onco Targets Ther; 2023; 16():651-652. PubMed ID: 37546174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].
    Onco Targets Ther; 2022; 15():681-682. PubMed ID: 35733651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.